- Sections
- A - Nécessités courantes de la vie
- A61K - Préparations à usage médical, dentaire ou pour la toilette
- A61K 31/664 - Amides des acides du phosphore
Détention brevets de la classe A61K 31/664
Brevets de cette classe: 360
Historique des publications depuis 10 ans
|
35
|
23
|
29
|
31
|
22
|
28
|
28
|
26
|
23
|
0
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| Ascentawits Pharmaceuticals, Ltd. | 69 |
18 |
| Pharmacyclics LLC | 244 |
12 |
| Royalty Security, LLC | 20 |
10 |
| The Johns Hopkins University | 5764 |
9 |
| Gilead Sciences, Inc. | 2112 |
5 |
| Kite Pharma, Inc. | 423 |
5 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2918 |
5 |
| Immunogenesis, Inc. | 20 |
5 |
| Wuhan Neurophth Biotechnology Limited Company | 24 |
5 |
| Indaptus Therapeutics, Inc. | 12 |
5 |
| Merck Sharp & Dohme Corp. | 2187 |
4 |
| Alla Chem, LLC | 53 |
4 |
| Eisai R&D Management Co., Ltd. | 1194 |
4 |
| IVACHTCHENKO, Alena Alexandrovna | 14 |
4 |
| Abraxis BioScience, LLC | 206 |
3 |
| Indiana University Research and Technology Corporation | 795 |
3 |
| Ivashchenko, Andrey Alexandrovich | 15 |
3 |
| Janssen Biotech, Inc. | 1597 |
3 |
| NED Biosystems, Inc. | 11 |
3 |
| OBI Pharma, Inc. | 128 |
3 |
| Autres propriétaires | 247 |